Facebook
Twitter
LinkedIn
ForwardDecember 20, 2024 MGH Prenatal Diagnosis Conference- Obstetrical Imaging and Beyond 2024-2025: xxx - Archive
Description
This activity provides on-demand archived lectures from the MGH Prenatal Diagnosis Conference- Obstetrical Imaging and Beyond 2024-2025 series. This multi-disciplinary conference with interplay of numerous specialists and subspecialists will discuss prenatal ultrasound findings, differential diagnosis, genetic testing algorithms, prenatal management, and postnatal outcome in a purposeful patient focused environment.
The physicians included are specialists and subspecialists representing obstetrician-gynecologists, maternal fetal medicine (MFM) clinicians, neonatologists, pediatric subspecialists (cardiologists, radiologists, neurologists, geneticists, and surgeons). The conference also includes maternal fetal medicine sonographers, genetic counselors, nurses, and others who care for our uniquely diverse patient population (pregnant patient and fetus) and may share their respective expertise to shed light on optimal management of difficult and complex clinical problems.
Course Directors:
Allan Nadel MD & Francine Hughes MD & Marti Soffer MD, MPH & Bryann Bromley MD
Coordinator: Ashley Cambridge (acambridge@mgb.org)
For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at partnerscpd@partners.org.
You may print individual certificates throughout the year; your cumulative list of sessions attended is accessible on your transcript.
Target Audience
This activity is intended for Physicians of various specialties, MFM obstetrical sonographers, Genetic counselors, Nurses with vested patient care interests and Allied support (Spiritual care, Palliative care, Cleft or Prosthetic teams) with specialties of Obstetrician-Gynecologists, Maternal Fetal Medicine sonologists (MD/DO) and sonographers (RDMS), Neonatologists and Pediatric geneticists (MD/DO) and genetic counselors (MS, CGC), Pediatric subspecialists: cardiology, radiology, neurology, nephrology, surgeons (urology/thoracic/cardiac/orthopedic), and any subspecialty area that will be part of a multidisciplinary team to care for the neonate after birth, Allied support care teams including orofacial cleft and prosthetic support teams, spiritual care providers and palliative care clinicians and Perinatal pathologists (MD/DO)
Learning Objectives
Upon completion of this activity, participants will be able to:
- Critically evaluate the quality of prenatal ultrasound imaging studies in an objective structured manner. For example: Were all the relevant images obtained? Were the images of sufficient quality to lead and refine a diagnosis? If not, what could be done to improve image quality? Were resources available to help the primary/secondary imager maximize the ultrasound technologies available to them?
- Understand and communicate the advanced genetic diagnostic tests that may apply to the phenotype reported by the ultrasound results. Recognize the limitations of genetic testing and next generation sequencing in terms of anticipated ‘positive’ results, turn-around time, and cost. Solicit evidence-based contributions with pediatric specialists (genetics, neonatologists) regarding information that may be helpful in counseling and prognosis for the pregnancy.
- Compare and contrast similar congenital anomalies. Solicit evidence-based contributions with pediatric specialists (neonatologist, cardiologists, neurologists, surgeons) regarding optimal patient management (e.g. timing, route, and location of delivery).
- Develop obstetrical ultrasound imaging protocols for common anomalies. What should be evaluated for a specific condition, what interval of follow-up is recommended? Expand protocols for genetic counseling and recommendations for diagnostic testing. Review of existing protocols when new information about any specific condition becomes available.
- Propose research aimed at improving prenatal diagnosis and management of congenital malformations.
Additional Information
Provided by Mass General Brigham
Course Directors
Allan Nadel, MD
Francine Hughes, MD
Marti Soffer MD, MPH
Bryann Bromley, MD
Faculty
DISCLOSURE SUMMARY OF RELEVANT FINANCIAL RELATIONSHIPS
MITIGATION STRATEGIES
Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public.
The following planners reported no relevant financial relationship with an ineligible company:
Allan Nadel MD
Francine Hughes MD
Marti Soffer MD, MPH
Bryann Bromley MD
Toni Hurton BS, RDMS
Ashley Page BS, RDMS
Arlin Delgado MD
Chelsea Mandigo MS, CGC
Kelsey Reynolds MS, CGC
The following speakers reported no relevant financial relationship with an ineligible company:
The following speakers reported a relevant financial relationship with an ineligible company:
ACCREDITATION
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditTM
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation